Treatment-Resistant Atopic Dermatitis in Adulthood: A Case Report

Atopic dermatitis (AD) is a chronic and relapsing skin condition that often begins in childhood but can persist or worsen into adulthood, significantly impacting quality of life. We present the case of a 41-year-old woman with long-standing, treatment-resistant AD, unresponsive to various systemic therapies including corticosteroids, methotrexate, thalidomide, and cyclosporine. Despite some control with methotrexate, she experienced frequent flares and side effects. This report highlights the clinical challenges and therapeutic considerations in managing chronic, treatment-resistant AD. It also shows the potential of targeted biologic therapies as more effective and better-tolerated alternatives. Early recognition of treatment resistance is crucial to improving patient outcomes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-10-15
DOI
https://doi.org/10.7759/cureus.94667
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment-Resistant Atopic Dermatitis in Adulthood: A Case Report

Fiorella Apuy Rodríguez, Mercedes Fernández, P. Cabrera Navarro, Jessica Arias et al.
Cureus
Dermatology and Skin Diseases
article

Treatment-Resistant Atopic Dermatitis in Adulthood: A Case Report

Fiorella Apuy Rodríguez, Mercedes Fernández, P. Cabrera Navarro, Jessica Arias, M Mora
article en

Abstract

Atopic dermatitis (AD) is a chronic and relapsing skin condition that often begins in childhood but can persist or worsen into adulthood, significantly impacting quality of life. We present the case of a 41-year-old woman with long-standing, treatment-resistant AD, unresponsive to various systemic therapies including corticosteroids, methotrexate, thalidomide, and cyclosporine. Despite some control with methotrexate, she experienced frequent flares and side effects. This report highlights the clinical challenges and therapeutic considerations in managing chronic, treatment-resistant AD. It also shows the potential of targeted biologic therapies as more effective and better-tolerated alternatives. Early recognition of treatment resistance is crucial to improving patient outcomes.

CureusVol. 17(10)
Universidad de Costa Rica (CR), Universidad de San Jose (CR)
Openalex Percentile: Top 50%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Treatment-Resistant Atopic Dermatitis in Adulthood: A Case Report — Fiorella Apuy Rodríguez, Mercedes Fernández, et al. · Cureus (2025) | TGRS Research Map | TGRS